|
|
Post by victoria on Oct 4, 2017 15:33:35 GMT -5
She is T1, but late onset (or late diagnosed). Classic person who could benefit from Afrezza. You listening Mike: with the UK heading to Brexit, theres every opening to start discussing this with the UK Medicines agency.
|
|
|
|
Post by pengiep on Oct 4, 2017 15:35:03 GMT -5
Should that dip in scrips due to reps removed from the field for training actually occur, that my friends is a BUY opportunity. I've got some cash coming and will use it for that purpose
|
|
|
|
Post by op2778 on Oct 4, 2017 15:37:16 GMT -5
I am not unduly concerned re Friday's scripts, I am more concerned about the short term dip we will get due to the sales reps being withdrawn from the field for a while to be retrained on the new FDA labelling (which will reduce sales predictably soon... watch out for the dip and do not worry IMHO) but that's a necessary step. With the new label they can sell this product effectively based on the actual drug performance and it is clearly best in class now. Any competent doctor can see that from the graphs. It then comes down to insurers (in the US at least) and the effectiveness of MNKD in helping people challenge insurer decisions which are adverse for patients. I believe we are now, indeed, in future mode. I am deeply deeply in the red even given today's moves but more optimistic than I have been in a while. Mike: at least announce you are looking at seeking UK approval. Its a big and reliable market, and based on clinical effectiveness. What you may lose in terms of the NHS negotiating competitive rates you gain in enormous bulk sales. Our Prime Minister is diabetic.... thats an 'in' if ever I saw one.... I am more concerned about the short term dip we will get due to the sales reps being withdrawn from the field for a while to be retrained on the new FDA labelling (which will reduce sales predictably soon... watch out for the dip and do not worry IMHO) but that's a necessary step What`s the logic behind this? I don´t think they withdrawn sales reps from the field. Read more: mnkd.proboards.com/thread/8702/volume-tree?page=8#ixzz4uZdF9zOh |
|
|
|
Post by peppy on Oct 4, 2017 15:54:16 GMT -5
|
|
|
|
Post by papanigon on Oct 4, 2017 15:58:43 GMT -5
Whew, pep I was getting nervous. You took awhile to post numbers. I thought the last dip was you selling off. 😉 |
|
|
|
Post by op2778 on Oct 4, 2017 16:07:57 GMT -5
interesting to see that last five days half float was traded (at least that's my understandment).
Float 104mm........traded last 5 days a total of 50.5mm.....http://www.4-traders.com/MANNKIND-CORPORATION-34185045/
Am i reading this correctly?
|
|
|
|
Post by mnholdem on Oct 4, 2017 16:08:09 GMT -5
I'll bet she was busy checking out travel brochures for the Danube.  |
|
|
|
Post by rravis1914 on Oct 4, 2017 16:12:10 GMT -5
CAN YOU IMAGINE? ?
What a sales meeting this one is!!! I was a rep years ago and sales meetings with a new exciting product were a real hoot!!
Can you imagine the excitement and the electricity there is at this meeting??
Can you imagine the celebrations taking place??
I feel like an old WAR HORSE pawing the ground as he hears the sound of battle!!
What a day!
RRAVIS 1914 |
|
|
|
Post by peppy on Oct 4, 2017 16:17:15 GMT -5
conspiracy theorist I am, it is running through the frontal lobe, did sanofi and goldman sacs conspire to first bankrupt the competition and now, snap up the shares cheap?
I love it that the continuous glucose monitors have been showing us for 2 years, afrezza is a fine, fine insulin. If we can see it, they,(sanofi and goldman sacs) have seen it just as long as we have.
I know it sounds crazy, however goldman sac played a huge part in bringing down the banking system I 2007-2009. Goldman sold the Colateral debt obligations and insured themselves through AIG and took out Lehman. Bernake and Yellon, 3 trillion plus printed, given to the broker dealers to buy the market. Goldman the numero ono broker dealer.
For the last year and 1/2 I have been in shock, the proof of fine on the CGM and the physicians. The saying, it's the insurance sweet heart.
damn.
The end. and apologies in advance.
|
|
|
|
Post by stinkypete on Oct 4, 2017 16:19:02 GMT -5
Could this be the long forecast 'short squeeze'
|
|
|
|
Post by peppy on Oct 4, 2017 16:19:18 GMT -5
interesting to see that last five days half float was traded (at least that's my understandment). Float 104mm........traded last 5 days a total of 50.5mm.....http://www.4-traders.com/MANNKIND-CORPORATION-34185045/ Am i reading this correctly? you are.
there are old threads, that talked about fake shares. Short Shares.....hmmmmm
and the stock is in play. so cheap you and load and unload and feel good, then bad that you unloaded too soon. or bad that you should have unloaded your shorts.
|
|
|
|
Post by op2778 on Oct 4, 2017 16:23:31 GMT -5
Hey peppy, my shares are locked until we hit $300 or BO or BK (not a typo mistake). LOL.
Let's see what will happens.
Let's see if the Wolf waves are right....Hope so...
|
|
|
|
Post by kc on Oct 4, 2017 16:25:41 GMT -5
In play as the blood is in the water. Something is in the horizon. Only the board and management knows what is about to unfold. AFREZZA is a great product the best is yet to happen.
|
|
|
|
Post by peppy on Oct 4, 2017 16:26:02 GMT -5
Could this be the long forecast 'short squeeze' I believe so. through the $6 which is only the 50% retracement of this wedge, is the .618. a break and hold there is test of top on this wedge, which is 10 bucks or 2 dollars pre/split.
I am thinking, the way price is acting, the label change and increased insurance, Mike said a large insurer coming on board, Jan, 2018, I am thinking the $10.
temper that with, today was a good day.
|
|
|
|
Post by lakers on Oct 4, 2017 16:28:09 GMT -5
How long will it take to breach the followings from now 10/4/17 :
52-week Hi $4.34, 12/20/2016
5-yr Hi $57.4, 6/30/2014
10-yr Hi $61.5, 9/22/2009
Would this make a good poll?
|
|
? 